Eli Lilly to seek obesity drug approval that could disrupt weight loss market Financial Times

Eli Lilly to seek obesity drug approval that could disrupt weight loss market  Financial Times

Eli Lilly will apply for approval of an obesity drug that a late-stage study showed can slash a persons body weight by almost a sixth, raising hopes for a new blockbuster treatment to tackle the glob… [+2761 chars]Read More

Leave a Reply

Your email address will not be published. Required fields are marked *